BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26453071)

  • 1. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
    Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
    Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.
    Hyland K; Surtees RA; Heales SJ; Bowron A; Howells DW; Smith I
    Pediatr Res; 1993 Jul; 34(1):10-4. PubMed ID: 7689195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
    Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
    Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
    Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
    Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reye syndrome: monoamine metabolites in ventricular fluid.
    Shaywitz BA; Venes J; Cohen DJ; Bowers MB
    Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
    Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
    Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid.
    Geracioti TD; Keck PE; Ekhator NN; West SA; Baker DG; Hill KK; Bruce AB; Wortman MD
    Biol Psychiatry; 1998 Aug; 44(3):228-33. PubMed ID: 9693394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid biogenic amine metabolites in children during treatment for acute lymphocytic leukemia.
    Silverstein FS; Hutchinson RJ; Johnston MV
    Pediatr Res; 1986 Apr; 20(4):285-91. PubMed ID: 2422625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolites of neurotransmitters in the cerebrospinal fluid in children].
    Zeman J; Böswart J
    Cesk Pediatr; 1991 May; 46(5):262-5. PubMed ID: 1716526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
    Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
    Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
    Shaywitz BA; Cohen DJ; Leckman JF; Young JG; Bowers MB
    Dev Med Child Neurol; 1980 Dec; 22(6):748-54. PubMed ID: 6161049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
    Zeman J; Böswart J
    Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
    Earley CJ; Hyland K; Allen RP
    Mov Disord; 2001 Jan; 16(1):144-9. PubMed ID: 11215576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.